How to Build a Business Case for Accelerated Underwriting Technology

Most carriers know accelerated underwriting technology works. The harder question is getting a board to fund it. The gap between "this is a good idea" and "here's the budget" is where most programs stall, sometimes for years.

It's not that executives are skeptical of the technology itself. What they're skeptical about is the financial model. They've seen enough vendor pitch decks with hockey-stick graphs and cherry-picked metrics. What they want is a business case that accounts for the costs they know about, the risks they suspect, and the timeline before the program pays for itself.

This is a breakdown of how carriers that have successfully launched accelerated underwriting programs actually built that case.

A 2022 Munich Re survey of 31 carriers with active accelerated underwriting programs found that average turnaround time dropped from 28 days under traditional underwriting to 8 days with accelerated workflows. PartnerRe's follow-up research reported similar ranges, with some carriers achieving decisions in under 48 hours for qualifying applicants.

Why the accelerated underwriting technology business case is harder than it looks

The obvious pitch writes itself: replace $150 paramedical exams with $40 electronic data pulls, cut cycle time from a month to a week, watch placement rates climb. Every vendor in the space makes some version of this argument.

The problem is that the costs are real and immediate while the benefits are distributed across multiple business lines and take quarters or years to fully materialize. A CFO looking at a $15 million technology investment wants to know when it breaks even. And the honest answer, for most programs, is somewhere between 18 months and three years, depending on how you count.

That uncertainty is what kills proposals. Not the technology. Not even the cost. The uncertainty.

Carriers that get approval tend to build their case around four financial pillars, each one modeled independently so the board can see which assumptions drive the outcome.

The four pillars of the business case

Pillar 1: Underwriting expense reduction

This is the most straightforward argument and usually the one with the most defensible numbers. Traditional fully underwritten life insurance involves paramedical exams ($80 to $150 per applicant), attending physician statements ($25 to $75 each, plus weeks of delay), and manual underwriter review time that varies wildly by case complexity.

Accelerated programs replace those steps with electronic data pulls: prescription history databases, motor vehicle records, MIB checks, and increasingly, electronic health records. The Society of Actuaries has published research showing per-policy underwriting expenses drop by more than 80% for cases that stay on the accelerated path.

But here's where models go wrong: they don't account for fallout. Not every application that enters the accelerated path stays there. Depending on eligibility criteria, 20% to 40% of applicants get referred to traditional review. Those cases cost more than if they'd gone through traditional from the start, because you've already paid for the electronic data before adding the paramedical exam and APS on top.

A realistic model needs to calculate blended cost per policy across three paths: fully accelerated, fallout to traditional, and direct-to-traditional for ineligible applicants.

Cost component	Traditional path	Accelerated path	Fallout path
Paramedical exam	$80–$150	$0	$80–$150
Attending physician statement	$25–$75	$0	$25–$75
Electronic data pulls (Rx, MVR, MIB)	$0–$15	$35–$55	$35–$55
EHR access (where used)	$0	$45–$65	$45–$65
Underwriter review time	45–90 min	5–15 min	60–120 min
Estimated total per policy	$180–$350	$40–$80	$250–$420

The blended number depends entirely on your acceleration rate and fallout rate. A carrier accelerating 60% of applications with a 25% fallout rate will see different economics than one accelerating 40% with 10% fallout.

Pillar 2: Placement rate improvement

Gen Re's 2025 Individual Life Next Gen Underwriting Survey found that 86% of applications going through automated workflows were ultimately placed, compared to 78% for accelerated workflows and 63% for fully underwritten ones. Those differences translate directly to revenue.

If a carrier underwrites 100,000 policies a year with an average premium of $1,200, moving the placement rate from 65% to 80% means 15,000 additional in-force policies. At $1,200 each, that's $18 million in new annual premium. Even after accounting for the cost of claims on those additional policies, the revenue impact dwarfs the technology investment.

The mechanism isn't complicated. Faster decisions give applicants less time to change their minds, shop competitors, or simply lose interest. A policy that takes four weeks to issue gives someone four weeks to reconsider. One that arrives in three days captures the motivation that existed when they applied.

This is the pillar that tends to win board arguments. Expense reduction is nice. Revenue growth is what gets funded.

Pillar 3: Mortality experience and risk adequacy

This is the pillar that makes actuaries nervous, and boards pay attention when actuaries are nervous.

Accelerated underwriting by definition uses less medical information to make decisions. The question that nobody can fully answer yet is whether the alternative data sources produce mortality experience equivalent to traditional underwriting. The programs haven't been running long enough for credible mortality studies at most carriers.

Munich Re's 2022 survey found that carriers were starting to develop mortality studies but acknowledged the data was still immature. Most programs had fewer than five years of mortality experience, and the policy durations skewed toward younger, healthier applicants who were more likely to qualify for acceleration in the first place.

Your business case needs to address this directly. Pretending the mortality risk doesn't exist won't survive an actuarial review. What works is modeling a range of scenarios: best case (mortality equivalent to traditional), moderate case (5-10% higher mortality in accelerated cohorts), and stress case (15-20% adverse mortality). Show the breakeven point under each scenario.

Most models show that even under the stress case, the expense savings and placement rate improvements more than compensate for moderately adverse mortality, especially in the first five years before significant claims develop.

Pillar 4: Competitive positioning and market share

This one is harder to put a dollar figure on, which is why it usually comes last. But it matters.

According to a 2026 industry analysis by SEND Technology, operational speed and digital capability have become "non-negotiable" for underwriters. Brokers are increasingly directing business to carriers that can provide fast decisions. A carrier that takes 25 days to issue a policy when competitors are doing it in five is losing distribution relationships, not just individual sales.

The competitive argument works best when you can tie it to specific distribution partners. If your top three MGAs or brokerage firms have told you they're shifting volume to faster carriers, that's a concrete data point. If you've lost RFPs because of cycle time, say so. Abstract "we need to stay competitive" arguments don't move boards. Specific lost revenue does.

What the technology stack actually costs

The business case needs a credible technology budget, and vendors are not always helpful here. They'll quote licensing fees but leave out the integration work, which is often the larger expense.

A realistic budget for a mid-size carrier covers several categories:

Investment category	Typical range	Notes
Data vendor contracts (Rx, MVR, EHR, MIB)	$500K–$2M/year	Scales with application volume
Rules engine / decision platform	$1M–$5M	Build vs. buy decision; ongoing maintenance either way
Predictive model development	$500K–$3M	Internal data science or vendor partnership
Core system integration	$2M–$8M	Connecting to policy admin, CRM, agent portals
Compliance and legal review	$200K–$500K	State-by-state regulatory analysis
Staff training and change management	$300K–$1M	Underwriters, agents, customer service
Total first-year investment	$4.5M–$19.5M	Wide range reflects carrier size and existing tech

The range is wide because it depends on what you're starting with. A carrier with a modern policy administration system and existing data vendor relationships is looking at the low end. One running a 1990s mainframe with manual workflows is looking at the high end, and probably a multi-year implementation timeline.

Structuring the presentation for board approval

Boards don't read 50-page business cases. They read the executive summary and then ask questions. Build for that reality.

Lead with the placement rate math. Revenue growth gets attention faster than cost savings. Show the current placement rate, the industry benchmark for accelerated programs, and the revenue impact of closing the gap.

Put the mortality risk analysis up front, not buried in an appendix. Boards respect transparency about risk more than they respect optimism. Show the scenario range, and explain what controls are in place: ongoing monitoring, cohort tracking, the ability to tighten eligibility criteria if mortality deviates.

Include a phased implementation plan. Very few boards will approve a full rollout on day one. A pilot program covering one product line or one distribution channel, with defined success criteria and a decision gate before expansion, is an easier approval than an all-or-nothing proposal.

NTT DATA's 2026 insurance outlook emphasized that carriers succeeding with digital transformation are those that "translate foresight into tangible use cases" rather than pursuing transformation for its own sake. Frame the accelerated underwriting program as a specific, measurable initiative with clear success criteria, not as part of a vague digital transformation.

Common objections and how to address them

"The mortality data isn't mature enough." True, and pretending otherwise won't work. Counter with the scenario analysis and the controls in place. Point out that Munich Re and Gen Re are both providing reinsurance support for accelerated programs, which means the reinsurance market has already priced this risk.

"We can't afford the implementation." Run the numbers on what you can't afford: losing distribution relationships to faster competitors, watching placement rates stagnate while accelerated carriers grow, paying $200 per underwrite when the industry is moving to $50. The cost of inaction has a number too.

"Our agents won't adopt it." Agent adoption depends on how the program is designed. If it makes their job easier and helps them close faster, adoption follows. The Society of Actuaries' research on accelerated programs noted that agent enthusiasm was consistently higher than carrier expectations when the programs reduced cycle time and simplified the application process.

"Regulators will push back." The NAIC's Accelerated Underwriting Working Group has been studying these programs since 2020 and has focused primarily on ensuring non-discrimination, not on blocking the technology itself. A solid compliance framework that addresses data privacy, algorithmic fairness, and state-specific requirements demonstrates regulatory readiness.

Current research and evidence

The evidence base for accelerated underwriting continues to grow, though gaps remain.

PartnerRe's accelerated underwriting survey, based on data from carriers with active programs, documented turnaround times averaging 8 days for accelerated cases versus the traditional 28-day average. Carriers using electronic health records reported the fastest times and the highest satisfaction with data quality.

Gen Re's 2025 Next Generation Underwriting Survey provided the most recent placement rate data, showing a 23-percentage-point difference between automated and fully underwritten placement rates (86% versus 63%). The survey covered carriers at various stages of program maturity.

The Society of Actuaries has published multiple research pieces on simplified and accelerated underwriting economics, with their analysis of per-policy cost reduction remaining one of the most cited figures in the industry.

Munich Re's ongoing survey program, which has tracked accelerated underwriting trends since 2016, provides longitudinal data on how programs evolve as they mature. Their findings on mortality experience, while still preliminary, have been cautiously optimistic.

The future of accelerated underwriting business cases

The business case is getting easier to make, not harder. Every year brings more mortality data from existing programs, more carriers reporting results, and more reinsurer comfort with the risk profile. The carriers building cases in 2026 have something their predecessors in 2018 didn't: a decade of industry experience to reference.

The harder question is becoming less "should we do this" and more "how fast can we move." Carriers in the SEND Technology analysis that delayed digital underwriting adoption were described as facing increasing competitive pressure, not from insurtech startups, but from other traditional carriers that moved first.

For carriers still building the case, the framework is straightforward. Model the four pillars independently. Be honest about mortality uncertainty. Lead with revenue impact. Propose a pilot, not a revolution. And bring specific numbers from your own distribution relationships, because the most persuasive business case isn't about the industry. It's about your carrier, your agents, and your applicants.

Platforms like Circadify are contributing to this shift by providing contactless health screening data that can feed accelerated underwriting workflows, adding a real-time biometric data layer without requiring paramedical exams.

Frequently asked questions

How long does it take for an accelerated underwriting program to break even?

Most carriers report breakeven between 18 months and three years, depending on implementation costs and application volume. The breakeven timeline shortens significantly when placement rate improvements are included in the calculation alongside expense savings.

What is the biggest risk in accelerated underwriting?

Mortality experience uncertainty. Because accelerated programs use less medical information, there is inherent uncertainty about whether long-term claims experience will match traditional underwriting. Ongoing cohort monitoring and scenario-based planning are the primary risk controls.

Do reinsurers support accelerated underwriting programs?

Yes. Munich Re, Gen Re, PartnerRe, and other major reinsurers actively support accelerated underwriting programs and have published research validating the approach. Reinsurer support is often a prerequisite for board approval at many carriers.

Can small carriers implement accelerated underwriting?

They can, though the economics look different. Smaller carriers typically partner with reinsurers or technology vendors rather than building in-house, which reduces upfront investment but increases ongoing per-policy costs. Several vendors now offer accelerated underwriting as a managed service, lowering the barrier to entry.